Low glycemic index treatment for seizures in Angelman syndrome

Epilepsia

Volumn 53, Issue 9, 2012, Pages 1498-1502

  Thibert, Ronald L ^a   Pfeifer, Heidi H ^a   Larson, Anna M ^a   Raby, Annabel R ^a   Reynolds, Ashley A ^a   Morgan, Amy K ^a   Thiele, Elizabeth A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angelman syndrome; Epilepsy; Ketogenic diet; Low glycemic index treatment; Refractory epilepsy

Indexed keywords

CLOBAZAM; ETIRACETAM; VALPROIC ACID;

ANTHROPOMETRY; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CARBOHYDRATE TOLERANCE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DIET THERAPY; DIETITIAN; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; FOLLOW UP; GLYCEMIC INDEX; HAPPY PUPPET SYNDROME; HUMAN; LABORATORY TEST; LIFESPAN; LOW CARBOHYDRATE DIET; LOW GLYCEMIC INDEX TREATMENT; MALE; NEUROLOGIST; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; SAMPLE SIZE; SCALES OF INDEPENDENT BEHAVIOR REVISED; STATISTICAL SIGNIFICANCE; VINELAND ADAPTIVE BEHAVIOR SCALE;

ANGELMAN SYNDROME; BLOOD GLUCOSE; CHILD, PRESCHOOL; COHORT STUDIES; DIET, CARBOHYDRATE-RESTRICTED; FEMALE; GLYCEMIC INDEX; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 84866055955     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03537.x     Document Type: Article

References (18)

1. Bailey EE, Pfeifer HH, Thiele EA,. (2005) The use of diet in the treatment of epilepsy. Epilepsy Behav 6: 4-8.
2. Buntinx IM, Hennekam RCM, Brouwer OF, Stroink H, Beuten J, Mangelschots K, Fryns JP,. (1995) Clinical profile of Angelman syndrome at different ages. Am J Med Genet A 56: 176-183.
3. Buoni S, Grosso S, Pucci L, Fois A,. (1999) Diagnosis of Angelman syndrome: clinical and EEG criteria. Brain Dev 21: 296-302.
4. Evangeliou A, Doulioglou V, Haidopoulou K, Aptouramani M, Spilioti M, Varlamis G,. (2010) Ketogenic diet in a patient with Angelman syndrome. Pediatr Int 52: 831-834.
5. Galván-Manso M, Campistol J, Conill J, Sanmartí F,. (2005) Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome. Epileptic Disord 7: 19-25.
6. Kishino T, Lalande M, Wagstaff J,. (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15: 70-73.
7. Kossoff EH, Zupec-Kania BA, Rho JM,. (2009) Ketogenic diets: an update for child neurologists. J Child Neurol 24: 979-988.
8. Minassian BA, DeLorey TM, Olsen RW, Philippart M, Bronstein Y, Zhang Q, Guerrini R, Van Ness P, Livet MO, Delgado-Escueta AV,. (1998) Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann Neurol 43: 485-493.
9. Muzykewicz DA, Lyczkowski DA, Memon N, Conant KD, Pfeifer HH, Thiele EA,. (2009) Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia 50: 1118-1126.
10. Nolt DH, Mott JM, Lopez WL,. (2003) Assessment of anticonvulsant effectiveness and safety in patients with Angelman's syndrome using an internet questionnaire. Am J Health Syst Pharm 60: 2583-2587.
11. Ohtsuka Y, Kobayashi K, Yoshinaga H, Ogino T, Ohmori I, Ogawa K, Oka E,. (2005) Relationship between severity of epilepsy and developmental outcome in Angelman syndrome. Brain Dev 27: 95-100.
12. Pfeifer HH, Thiele EA,. (2005) Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 65: 1810-1812.
13. Pfeifer HH, Lyczkowski DA, Thiele EA,. (2008) Low glycemic index treatment: implementation and new insights into efficacy. Epilepsia 49: 42-45.
14. Ruggieri M, McShane MA,. (1998) Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child 79: 423-426.
15. Stein D, Chetty M, Rho JM,. (2010) A "happy" toddler presenting with sudden, life-threatening seizures. Semin Pediatr Neurol 17: 35-38.
16. Thibert RL, Conant KD, Braun EK, Bruno PL, Said RR, Nespeca MP, Thiele EA,. (2009) Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. Epilepsia 50: 2369-2376.
17. Valente KD, Koiffmann CP, Fridman C, Varella M, Kok F, Andrade JQ, Grossmann R, Marques-Dias M,. (2006) Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13. Arch Neurol 63: 122-128.
18. Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A, Schinzel AA, Summers JA, Wagstaff J,. (2006) Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet 140: 413-418.